Extending the concept further, we hypothesize that TNR-binding compounds may induce a variety of sequences to form specific cognate structural motif(s) representing a substantial step towards the development of new therapeutic or diagnostic agents to treat these neurological diseases. The gene discussed is TNR; the disease is nervous system disorder.